Therapeutic Solutions International Granted Landmark United States Patent on Ability of QuadraMune® Nutraceutical to Repair Injured Brains
Commercially Available Nutraceutical Potentially Effective Against COVID-19 Brain Fog
The patent covers protection of brain cells, as well as stimulation of brain repair, using ingredients in QuadraMune® and variations of the ingredients. The Company has previously demonstrated synergy between the ingredients in this nutraceutical. This is the third patent being granted on QuadraMune®, which is commercially available from numerous sources, including on Amazon1. The first patent covered the use of QuadraMune® for immune modulation in cancer and COVID-192. The second covered prevention and treatment of COVID-193 by QuadraMune® administration.
“Having witnessed first-hand positive patient experiences with QuadraMune®, as well as having led the research for development and testing of this novel “first-in-class” nutraceutical, we are very proud to have been granted exclusivity by the United States Government for using this nutraceutical for neuroprotection and neuroregeneration," said Dr.
Previously the Company has shown that QuadraMune® can increase the ability of natural killer cells to kill target cells, which is an important part of the body’s defense mechanisms to viruses and cancer. Interestingly, addition of the diabetes drug metformin increased activity of QuadraMune®.
“We are thankful for the leadership role of
About
1 Amazon.com:
2
3
View source version on businesswire.com: https://www.businesswire.com/news/home/20221010005391/en/
ir@tsoimail.com
Source: